Mostrar el registro sencillo del ítem

dc.creatorAndrade, Laura
dc.creatorCaraveo-Anduaga, Jorge J.
dc.creatorBerglund, Patricia
dc.creatorBijl, Rob V.
dc.creatorDe Graaf, Ron
dc.creatorVollebergh, Wilma
dc.creatorDragomirecka, Eva
dc.creatorKohn, Robert
dc.creatorKeller, Martin
dc.creatorKessler, Ronald C.
dc.creatorKawakami, Norito
dc.creatorKilic, Cengiz
dc.creatorOfford, David
dc.creatorUstun, T. Bedirhan
dc.creatorVicente, B.
dc.creatorWittchen, Hans-Ulrich
dc.date.accessioned2017-06-29T04:30:08Z
dc.date.available2017-06-29T04:30:08Z
dc.date.issued2003es_ES
dc.identifier393es_ES
dc.identifier.issn1049-8931es_ES
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/5084
dc.identifier.urihttps://doi.org/10.1002/mpr.138es_ES
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878531/es_ES
dc.language.isoenges_ES
dc.relation12 (1) 3-21 p.es_ES
dc.relationversión del editores_ES
dc.rightsacceso cerradoes_ES
dc.titleThe epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveyses_ES
dc.typearticlees_ES
dc.contributor.affiliationMax Planck Inst Psychiat, D-80804 Munich, Germanyes_ES
dc.relation.jnabreviadoINT J METHODS PSYCHIATR RESes_ES
dc.relation.journalInternational Journal of Methods in Psychiatric Researches_ES
dc.date.published2003es_ES
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñizes_ES
dc.identifier.eissn1557-0657es_ES
dc.identifier.doi10.1002/mpr.138es_ES
dc.description.abstractotrodiomaAbsence of a common diagnostic interview has hampered cross-national syntheses of epidemiological evidence on major depressive episodes (MDE). Community epidemiological surveys using the World Health Organization Composite International Diagnostic Interview administered face-to-face were carried out in 10 countries in North America (Canada and the US), Latin America (Brazil, Chile, and Mexico), Europe (Czech Republic, Germany, the Netherlands, and Turkey), and Asia (Japan). The total sample size was more than 37,000. Lifetime prevalence estimates of hierarchy-free DSM-III-R-DSM-IV MDE varied widely, from 3% in Japan to 16.9% in the US, with the majority in the range of 8% to 12%. The 12-month-life time prevalence ratio was in the range 40% to 55%, the 30-day-12-month prevalence ratio in the range 45% to 65%, and median age of onset in the range 20 to 25 in most countries. Consistent socio-demographic correlates included being female and unmarried. Respondents in recent cohorts reported higher lifetime prevalence, but lower persistence than those in earlier cohorts. Major depressive episodes were found to be strongly co-morbid with, and temporally secondary to, anxiety disorders in all countries, with primary panic and generalized anxiety disorders the most powerful predictors of the first onset of secondary MDE. Major depressive episodes are a commonly occurring disorder that usually has a chronic-intermittent course. Effectiveness trials are needed to evaluate the impact of early detection and treatment on the course of MDE as well as to evaluate whether timely treatment of Primary anxiety disorders would reduce the subsequent onset, persistence, and severity of secondary MDE.es_ES
dc.subject.koMajor depressiones_ES
dc.subject.koEpidemiologyes_ES
dc.subject.koICPE surveyses_ES


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem